Chief Executive Officer Memgen Chairman and Founder of HealthCare Royalty Partners
President & CEO, BioVentrix
Mr. Dillon is the President & CEO of BioVentrix, an innovative company focused on improving treatment for heart failure. He started at St. Jude Medical in 2011 and has held a series of increasingly responsible corporate strategic and sales leadership positions. Within these roles, he drove market development and new technology adoption, executed capital/consumable sales strategies and built high performance elite commercial teams focused on the sales and marketing of complex and innovative medical devices. Dillon was also involved with multiple highly successful medical device companies including startups VNUS Medical Technologies, Perclose, Heart Technologies, and Devices for Vascular Intervention as a key contributor to their acquisition and exit, as well as providing prominent leadership related to both sales and business development. Prior to joining St. Jude, he also held senior executive sales and marketing positions with such companies as Abiomed, TherOx and InfraReDx, where he was intimately involved with global clinical development and commercial distribution.
General Counsel and Chief Compliance Officer, Elevate Ventures
Former Head of IT Quality, Roche Diagnostics
Mr. McClure has over 2 decades of global experience in the Pharmaceutical and Medical Device industries. He has served in leadership roles in the areas of Quality, Regulatory, Clinical Trials and Information Technology. In these roles, Mr. McClure has supported successful regulatory clearances and approvals necessary to effectively launch new technologies and products. He has also developed global teams to implement these new technologies and products.
Mr. McClure is currently the President of F&M Investment Office, LLC. F&M is an entrepreneurial-focused Single Family Office with over $50 million in investments across a diverse group of industries including biotechnology, information technology, real estate and hospitality. In his role as President, he leverages his industry experience, operational savvy and financial acumen to lead F&M's portfolio of investments. In addition to managing all investments, he holds seats on a number of Boards representing F&M where he provides oversight, input and direction in the areas of clinical trials, quality, regulatory and organizational management. Mr. McClure is also the President of the Arthur Dean Family Foundation - a private foundation established by the McClure family that is committed to providing central Indiana youth with opportunities that will lead to their development, well-being and long-term ability to thrive.
CEO, FAST BioMedical
Medical Director/Founder, FAST BioMedical
Vice President of Clinical Operations/Founder, FAST BioMedical